Physician profile
Robyn White
NPI 1093424228
$2,440.12
in general payments reported to CMS, 2019-2025
20 companies · $910 in 2025
The $910 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $664 · 2024: $867 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,440.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.27 | 2023-2025 | |
| Glaxosmithkline, LLC. | $338.42 | 2023-2025 | Benlysta |
| Janssen Biotech, INC. | $306.09 | 2023-2025 | Tremfya, Simponi Aria |
| Amgen INC. | $235.48 | 2023-2025 | Enbrel, Otezla, Tavneos |
| Ani Pharmaceuticals, INC. | $188.34 | 2023-2025 | Purified Cortrophin Gel |
| Pharming Healthcare, INC. | $111.67 | 2023 | Ruconest |
| Mallinckrodt Hospital Products INC. | $83.28 | 2025 | Acthar |
| Pfizer INC. | $80.80 | 2024-2025 | |
| Ucb, INC. | $74.19 | 2023-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $72.73 | 2023-2025 | Saphnelo |
| Janssen Scientific Affairs, LLC | $55.31 | 2023 | Tremfya |
| Radius Health, INC. | $54.16 | 2025 | Tymlos |
| Alexion Pharmaceuticals, INC. | $53.79 | 2023-2024 | Strensiq |
| Novartis Pharmaceuticals Corporation | $30.65 | 2023 | |
| Tersera Therapeutics LLC | $25.99 | 2025 | Quzyttir |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $23.45 | 2023 | Lupkynis |
| Celgene Corporation | $22.59 | 2024 | Orencia |
| Scilex Pharmaceuticals INC. | $17.97 | 2024 | |
| Organon LLC | $16.18 | 2025 | Hadlima |
| Sobi, INC | $15.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.